Connexin43 reduces melanoma growth within a keratinocyte microenvironment and during tumorigenesis in vivo

Journal of Biological Chemistry

Volumn 289, Issue 3, 2014, Pages 1592-1603

  Ableser, Mark J ^a   Penuela, Silvia ^a   Lee, Jack ^a   Shao, Qing ^a   Laird, Dale W ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULAR PROLIFERATIONS; CHICKEN CHORIOALLANTOIC MEMBRANES; ECTOPIC EXPRESSIONS; GAP JUNCTIONAL INTERCELLULAR COMMUNICATIONS; MELANOMA CELLS; MICROENVIRONMENTS; TUMOR SUPPRESSORS; WESTERN BLOTTING;

CELL CULTURE; CELL PROLIFERATION; ONCOLOGY; TUMORS;

DERMATOLOGY;

CONNEXIN 26; CONNEXIN 43; GREEN FLUORESCENT PROTEIN; GAP JUNCTION PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CELL COMMUNICATION; CELL PROLIFERATION; CHORIOALLANTOIS; CONTROLLED STUDY; EMBRYO; GAP JUNCTION; IMMUNOFLUORESCENCE; IN VIVO STUDY; KERATINOCYTE; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR MICROENVIRONMENT; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CHICK EMBRYO; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; CELL COMMUNICATION; CELL LINE, TUMOR; CHICK EMBRYO; CONNEXIN 43; CONNEXINS; GAP JUNCTIONS; GENE EXPRESSION REGULATION, NEOPLASTIC; KERATINOCYTES; MELANOMA; MICE; TUMOR MICROENVIRONMENT; TUMOR SUPPRESSOR PROTEINS;

EID: 84892665526     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.507228     Document Type: Article

References (55)

1. Söhl, G., and Willecke, K. (2003) An update on connexin genes and their nomenclature in mouse and man. Cell Commun. Adhes. 10, 173-180 (Pubitemid 38081368)
2. Wang, N., De Bock, M., Decrock, E., Bol, M., Gadicherla, A., Vinken, M., Rogiers, V., Bukauskas, F. F., Bultynck, G., and Leybaert, L. (2013) Paracrine signaling through plasma membrane hemichannels. Biochim. Biophys. Acta 1828, 35-50
3. Richard, G. (2000) Connexins. A connection with the skin. Exp. Dermatol. 9, 77-96
4. Hsu, M., Andl, T., Li, G., Meinkoth, J. L., and Herlyn, M. (2000) Cadherin repertoire determines partner-specific gap junctional communication during melanoma progression. J. Cell Sci. 113, 1535-1542 (Pubitemid 30312502)
5. Masuda, M., Usami, S., Yamazaki, K., Takumi, Y., Shinkawa, H., Kurashima, K., Kunihiro, T., and Kanzaki, J. (2001) Connexin 26 distribution in gap junctions between melanocytes in the human vestibular dark cell area. Anat. Rec. 262, 137-146 (Pubitemid 32147730)
6. Haass, N. K., and Herlyn, M. (2005) Normal human melanocyte homeostasis as a paradigm for understanding melanoma. J. Investig. Dermatol. Symp. Proc. 10, 153-163
7. Seiberg, M., Paine, C., Sharlow, E., Andrade-Gordon, P., Costanzo, M., Eisinger, M., and Shapiro, S. S. (2000) The protease-activated receptor 2 regulates pigmentation via keratinocyte-melanocyte interactions. Exp. Cell Res. 254, 25-32 (Pubitemid 30066728)
8. Shih, I. M., Elder, D. E., Hsu, M. Y., and Herlyn, M. (1994) Regulation of Mel-CAM/MUC18 expression on melanocytes of different stages of tumor progression by normal keratinocytes. Am. J. Pathol. 145, 837-845 (Pubitemid 24320601)
9. Valyi-Nagy, I. T., Hirka, G., Jensen, P. J., Shih, I. M., Juhasz, I., and Herlyn, M. (1993) Undifferentiated keratinocytes control growth, morphology, and antigen expression of normal melanocytes through cell-cell contact. Lab. Invest. 69, 152-159 (Pubitemid 23262495)
10. Loewenstein, W. R., and Kanno, Y. (1966) Intercellular communication and the control of tissue growth. Lack of communication between cancer cells. Nature 209, 1248-1249
11. Krutovskikh, V., Mazzoleni, G., Mironov, N., Omori, Y., Aguelon, A. M., Mesnil, M., Berger, F., Partensky, C., and Yamasaki, H. (1994) Altered homologous and heterologous gap-junctional intercellular communication in primary human liver tumors associated with aberrant protein localization but not gene mutation of connexin 32. Int. J. Cancer 56, 87-94 (Pubitemid 24044798)
12. Yamaoka, K., Nouchi, T., Tazawa, J., Hiranuma, S., Marumo, F., and Sato, C. (1995) Expression of gap junction protein connexin 32 and E-cadherin in human hepatocellular carcinoma. J. Hepatol. 22, 536-539
13. Mesnil, M., Crespin, S., Avanzo, J. L., and Zaidan-Dagli, M. L. (2005) Defective gap junctional intercellular communication in the carcinogenic process. Biochim. Biophys. Acta 1719, 125-145 (Pubitemid 41785641)
14. Cronier, L., Crespin, S., Strale, P. O., Defamie, N., and Mesnil, M. (2009) Gap junctions and cancer. New functions for an old story. Antioxid. Redox. Signal 11, 323-338
15. Eghbali, B., Kessler, J. A., Reid, L. M., Roy, C., and Spray, D. C. (1991) Involvement of gap junctions in tumorigenesis. Transfection of tumor cells with connexin 32 cDNA retards growth in vivo. Proc. Natl. Acad. Sci. U.S.A. 88, 10701-10705 (Pubitemid 21915905)
16. McLachlan, E., Shao, Q., Wang, H. L., Langlois, S., and Laird, D. W. (2006) Connexins act as tumor suppressors in three-dimensional mammary cell organoids by regulating differentiation and angiogenesis. Cancer Res. 66, 9886-9894 (Pubitemid 44672040)
17. Zhu, D., Caveney, S., Kidder, G. M., and Naus, C. C. (1991) Transfection of C6 glioma cells with connexin 43 cDNA. Analysis of expression, intercellular coupling, and cell proliferation. Proc. Natl. Acad. Sci. U.S.A. 88, 1883-1887 (Pubitemid 21916331)
18. Hirschi, K. K., Xu, C. E., Tsukamoto, T., and Sager, R. (1996) Gap junction genes Cx26 and Cx43 individually suppress the cancer phenotype of human mammary carcinoma cells and restore differentiation potential. Cell Growth Differ. 7, 861-870 (Pubitemid 26360725)
19. Loewenstein, W. R., and Rose, B. (1992) The cell-cell channel in the control of growth. Semin. Cell Biol. 3, 59-79
20. King, T. J., and Lampe, P. D. (2004) The gap junction protein connexin32 is a mouse lung tumor suppressor. Cancer Res. 64, 7191-7196 (Pubitemid 39372049)
21. Temme, A., Buchmann, A., Gabriel, H. D., Nelles, E., Schwarz, M., and Willecke, K. (1997) High incidence of spontaneous and chemically induced liver tumors in mice deficient for connexin32. Curr. Biol. 7, 713-716 (Pubitemid 27408873)
22. Naus, C. C., and Laird, D. W. (2010) Implications and challenges of connexin connections to cancer. Nat. Rev. Cancer 10, 435-441
23. Ito, A., Katoh, F., Kataoka, T. R., Okada, M., Tsubota, N., Asada, H., Yoshikawa, K., Maeda, S., Kitamura, Y., Yamasaki, H., and Nojima, H. (2000) A role for heterologous gap junctions between melanoma and endothelial cells in metastasis. J. Clin. Invest. 105, 1189-1197 (Pubitemid 30266071)
24. Su, Y. A., Bittner, M. L., Chen, Y., Tao, L., Jiang, Y., Zhang, Y., Stephan, D. A., and Trent, J. M. (2000) Identification of tumor-suppressor genes using human melanoma cell lines UACC903, UACC903(+6), and SRS3 by comparison of expression profiles. Mol. Carcinog. 28, 119-127 (Pubitemid 30432480)
25. Bagnato, A., Rosanò, L., Spinella, F., Di Castro, V., Tecce, R., and Natali, P. G. (2004) Endothelin B receptor blockade inhibits dynamics of cell interactions and communications in melanoma cell progression. Cancer Res. 64, 1436-1443 (Pubitemid 38235614)
26. Stoletov, K., Strnadel, J., Zardouzian, E., Momiyama, M., Park, F. D., Kelber, J. A., Pizzo, D. P., Hoffman, R., VandenBerg, S. R., and Klemke, R. L. (2013) Role of connexins in metastatic breast cancer and melanoma brain colonization. J. Cell Sci. 126, 904-913
27. Saito-Katsuragi, M., Asada, H., Niizeki, H., Katoh, F., Masuzawa, M., Tsutsumi, M., Kuniyasu, H., Ito, A., Nojima, H., and Miyagawa, S. (2007) Role for connexin 26 in metastasis of human malignant melanoma. Communication between melanoma and endothelial cells via connexin 26. Cancer 110, 1162-1172 (Pubitemid 47312883)
28. Hsu, M. Y., Meier, F. E., Nesbit, M., Hsu, J. Y., Van Belle, P., Elder, D. E., and Herlyn, M. (2000) E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors. Am. J. Pathol. 156, 1515-1525 (Pubitemid 30646691)
29. Qin, H., Shao, Q., Curtis, H., Galipeau, J., Belliveau, D. J., Wang, T., Alaoui-Jamali, M. A., and Laird, D. W. (2002) Retroviral delivery of connexin genes to human breast tumor cells inhibits in vivo tumor growth by a mechanism that is independent of significant gap junctional intercellular communication. J. Biol. Chem. 277, 29132-29138
30. Harris, A. L. (2007) Connexin channel permeability to cytoplasmic molecules. Prog. Biophys. Mol. Biol. 94, 120-143 (Pubitemid 46782979)
31. Penuela, S., Gyenis, L., Ablack, A., Churko, J. M., Berger, A. C., Litchfield, D. W., Lewis, J. D., and Laird, D. W. (2012) Loss of pannexin 1 attenuates melanoma progression by reversion to a melanocytic phenotype. J. Biol. Chem. 287, 29184-29193
32. Laird, D. W., Jordan, K., Thomas, T., Qin, H., Fistouris, P., and Shao, Q. (2001) Comparative analysis and application of fluorescent proteintagged connexins. Microsc. Res. Tech. 52, 263-272 (Pubitemid 32126136)
33. Thomas, T., Jordan, K., Simek, J., Shao, Q., Jedeszko, C., Walton, P., and Laird, D. W. (2005) Mechanisms of Cx43 and Cx26 transport to the plasma membrane and gap junction regeneration. J. Cell Sci. 118, 4451-4462 (Pubitemid 41556343)
34. Kalra, J., Shao, Q., Qin, H., Thomas, T., Alaoui-Jamali, M. A., and Laird, D. W. (2006) Cx26 inhibits breast MDA-MB-435 cell tumorigenic properties by a gap junctional intercellular communication-independent mechanism. Carcinogenesis 27, 2528-2537 (Pubitemid 44884112)
35. Falk, M. M. (2000) Connexin-specific distribution within gap junctions revealed in living cells. J. Cell Sci. 113, 4109-4120 (Pubitemid 32194535)
36. Jordan, K., Solan, J. L., Dominguez, M., Sia, M., Hand, A., Lampe, P. D., and Laird, D. W. (1999) Trafficking, assembly, and function of a connexin43- green fluorescent protein chimera in live mammalian cells. Mol. Biol. Cell 10, 2033-2050
37. Thomas, T., Telford, D., and Laird, D. W. (2004) Functional domain mapping and selective trans-dominant effects exhibited by Cx26 disease-causing mutations. J. Biol. Chem. 279, 19157-19168 (Pubitemid 38623347)
38. Weber, P. A., Chang, H. C., Spaeth, K. E., Nitsche, J. M., and Nicholson, B. J. (2004) The permeability of gap junction channels to probes of different size is dependent on connexin composition and permeant-pore affinities. Biophys. J. 87, 958-973 (Pubitemid 39095076)
39. Sato, H., Hagiwara, H., Ohde, Y., Senba, H., Virgona, N., and Yano, T. (2007) Regulation of renal cell carcinoma cell proliferation, invasion and metastasis by connexin 32 gene. J. Membr. Biol. 216, 17-21 (Pubitemid 350194811)
40. Huang, R. P., Fan, Y., Hossain, M. Z., Peng, A., Zeng, Z. L., and Boynton, A. L. (1998) Reversion of the neoplastic phenotype of human glioblastoma cells by connexin 43 (cx43). Cancer Res. 58, 5089-5096 (Pubitemid 28521167)
41. Ionta, M., Ferreira, R. A., Pfister, S. C., and Machado-Santelli, G. M. (2009) Exogenous Cx43 expression decrease cell proliferation rate in rat hepatocarcinoma cells independently of functional gap junction. Cancer Cell Int. 9, 22
42. Princen, F., Robe, P., Gros, D., Jarry-Guichard, T., Gielen, J., Merville, M. P., and Bours, V. (2001) Rat gap junction connexin-30 inhibits proliferation of glioma cell lines. Carcinogenesis 22, 507-513 (Pubitemid 32203832)
43. Zhang, Y. W., Nakayama, K., Nakayama, K., and Morita, I. (2003) A novel route for connexin 43 to inhibit cell proliferation. Negative regulation of S-phase kinase-associated protein (Skp 2). Cancer Res. 63, 1623-1630 (Pubitemid 36373653)
44. Chen, S. C., Pelletier, D. B., Ao, P., and Boynton, A. L. (1995) Connexin43 reverses the phenotype of transformed cells and alters their expression of cyclin/cyclin-dependent kinases. Cell Growth Differ. 6, 681-690
45. Omori, Y., and Yamasaki, H. (1999) Gap junction proteins connexin32 and connexin43 partially acquire growth-suppressive function in HeLa cells by deletion of their C-terminal tails. Carcinogenesis 20, 1913-1918 (Pubitemid 29476116)
46. Laird, D. W. (2010) The gap junction proteome and its relationship to disease. Trends Cell Biol. 20, 92-101
47. Zucker, S. N., Bancroft, T. A., Place, D. E., Des Soye, B., Bagati, A., and Berezney, R. (2013) A dominant negative Cx43 mutant differentially affects tumorigenic and invasive properties in human metastatic melanoma cells. J. Cell Physiol. 228, 853-859
48. Elzarrad, M. K., Haroon, A., Willecke, K., Dobrowolski, R., Gillespie, M. N., and Al-Mehdi, A. B. (2008) Connexin-43 upregulation in micrometastases and tumor vasculature and its role in tumor cell attachment to pulmonary endothelium. BMC Med. 6, 20
49. Pollmann, M. A., Shao, Q., Laird, D. W., and Sandig, M. (2005) Connexin 43 mediated gap junctional communication enhances breast tumor cell diapedesis in culture. Breast Cancer Res. 7, R522-534
50. Haass, N. K., Smalley, K. S., and Herlyn, M. (2004) The role of altered cell-cell communication in melanoma progression. J. Mol. Histol. 35, 309-318 (Pubitemid 40585316)
51. Girolamo, F., Elia, G., Errede, M., Virgintino, D., Cantatore, S., Lorusso, L., Roncali, L., Bertossi, M., and Ambrosi, L. (2006) In vivo assessment of epichlorohydrin effects. The chorioallantoic membrane model. Med. Sci. Monit. 12, BR21 BR27 (Pubitemid 43116649)
52. Langlois, S., Cowan, K. N., Shao, Q., Cowan, B. J., and Laird, D. W. (2010) The tumor-suppressive function of Connexin43 in keratinocytes is mediated in part via interaction with caveolin-1. Cancer Res. 70, 4222-4232
53. Fu, C. T., Bechberger, J. F., Ozog, M. A., Perbal, B., and Naus, C. C. (2004) CCN3 (NOV) interacts with connexin43 in C6 glioma cells. Possible mechanism of connexin-mediated growth suppression. J. Biol. Chem. 279, 36943-36950 (Pubitemid 39129044)
54. Leithe, E., Kjenseth, A., Sirnes, S., Stenmark, H., Brech, A., and Rivedal, E. (2009) Ubiquitylation of the gap junction protein connexin-43 signals its trafficking from early endosomes to lysosomes in a process mediated by Hrs and Tsg101. J. Cell Sci. 122, 3883-3893
55. Kieken, F., Mutsaers, N., Dolmatova, E., Virgil, K., Wit, A. L., Kellezi, A., Hirst-Jensen, B. J., Duffy, H. S., and Sorgen, P. L. (2009) Structural and molecular mechanisms of gap junction remodeling in epicardial border zone myocytes following myocardial infarction. Circ. Res. 104, 1103-1112